ArticleSubstance abuse treatment, prevention, and policy2025
Public support of and attitudes toward decriminalization of possession of illegal drugs among the general population in British Columbia.
Article in Substance abuse treatment, prevention, and policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Impact of drug decriminalization and recriminalization on drug-related crime and health outcomes in British Columbia: a population-level time-series analysis.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026Article
- Access to health and harm reduction services during drug decriminalization in British Columbia, Canada: a mixed-method study.BMC public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundDecriminalization of possession of illegal drugs was implemented in British Columbia, Canada for a three-year period starting from January 31, 2023. As public sentiment played a large role in the outcome of a similar reform in Oregon, United States, it is important to examine the public’s perceptions of this policy. We examined public support of and attitudes toward decriminalization.
methodsData were from an online, non-probability, cross-sectional survey of adults who spoke English and resided in British Columbia (N = 1,202; March to April 2024). One item assessed support of decriminalization, and ten items assessed attitudes toward decriminalization. The analytical strategy involved descriptive statistics and multinomial logistic regression.
resultsIn regards to support of decriminalization, 41% did not support decriminalization, 26% were neutral or not sure about supporting decriminalization and 33% supported decriminalization. The majority agreed that decriminalization will reduce criminalization of drugs (50%) and encourage drug use experimentation (53%). More agreed (44%) than disagreed (28%) that decriminalization made them feel less safe. The majority disagreed that decriminalization will reduce overdoses (55%) and drug-related crimes (50%). Older age was associated with an increased likelihood of not supporting decriminalization compared with being neutral or not sure about supporting decriminalization (OR [95% CI]: 1.97 [1.35 to 2.88] for 40 to 59 years old; 1.89 [1.19 to 3.02] for ≥ 60 years old), and female or another gender was associated with a decreased likelihood of supporting decriminalization compared with being neutral or not sure about supporting decriminalization (0.66 [0.47 to 0.91]).
conclusionsPublic support of decriminalization was not strong, which may be rooted in lack of robust confidence in decriminalization to achieve its goals and increased public safety concerns. These findings necessitate ongoing evaluations of the policy and increasing knowledge mobilization activities to keep the public abreast of the latest developments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.